China NMPA Drug Inspection - Taixing Hengyuan Huakang Pharmaceutical Plastics Co., Ltd. - Polyester/aluminum/polyethylene pharmaceutical packaging composite film
China NMPA drug inspection for Taixing Hengyuan Huakang Pharmaceutical Plastics Co., Ltd. published May 25, 2017. Drug: Polyester/aluminum/polyethylene pharmaceutical packaging composite film. An announcement by the State Administration for Market Regulation, published on May 25, 2017, detailed findings of subst
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Taixing Hengyuan Huakang Pharmaceutical Plastics Co., Ltd. published May 25, 2017. Drug: Polyester/aluminum/polyethylene pharmaceutical packaging composite film. An announcement by the State Administration for Market Regulation, published on May 25, 2017, detailed findings of subst
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox